Search results

Page results

• UCLH begins trial of blood plasma exchange for Covid-19

  UCLH has recruited the first patient to a trial that will look at whether giving blood plasma to patients hospitalised with severe Covid-19 infection can reduce illness severity and mortality.

• Alternating vaccines trial to include two additional vaccines

  The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.

• Covid-19 variant more transmissible but does not increase disease severity in hospitalised patients

  A study of patients at UCLH and North Middlesex University Hospital published in The Lancet Infectious Diseases suggests that the B.1.17. variant of Covid-19 is not associated with more severe illness and death, but appears to lead to higher virus load.

• World’s first COVID-19 vaccine alternating dose study launches at UCLH

  The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.

• Coping with loneliness - by Emma Breger, Support and information specialist

  Emma, our support and information specialist, gives tips to overcome loneliness.

• Sleep tips for families and young people

  Sleep tips for families and young people with diabetes

• UCLH leads the way with service to treat Covid-19 patients with lingering symptoms

  UCLH has developed a post-Covid-19 service to help survivors of the virus with their long-term recovery.

• Access to diagnostics during COVID-19

  Further information on access to diagnostics in cardiology, endoscopy, imaging and gynaecology departments at UCLH.

• Carers

  We know that lots of people do not see themselves as ‘carers’ in a formal sense. You might think of what you do as your duty or responsibility because the person you are caring for is a…

• UCLH doses first patient in the world in Covid-19 antibody trial

  UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.